ABOS - Acumen Pharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - ABOS (1576885)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
7 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-01-19
ABOSOconnell Daniel JosephPres, CEOS - Sale$3.47-15,200502,485-3%-$52,753
2024-01-19
ABOSMeisner Derek MGC, Corp SecS - Sale$3.48-8,933108,867-8%-$31,048
2024-01-18
ABOSZuga MattCFO, Chief Business OfficerS - Sale$3.71-4,242211,445-2%-$15,717
2024-01-18
ABOSSiemers EricChief Medical OfficerS - Sale$3.71-3,124117,576-3%-$11,604
2024-01-18
ABOSBarton RussellCOOS - Sale$3.73-2,83396,867-3%-$10,555
D
2023-08-17
ABOSIves Jeffrey L.DirS - Sale+OE$6.49-41,9490-100%-$272,334
2023-07-21
ABOSRa Capital Management, L.P.Dir, 10%P - Purchase$7.75+5,161,29014,932,063+53%+$39,999,998

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top